Rythmol and Gabapentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rythmol (propafenone hydrochloride) and Gabapentin (gabapentin). Common drug interactions include coronary artery disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Rythmol and Gabapentin. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Rythmol?

Rythmol has active ingredients of propafenone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 3,638 Rythmol users. Check the latest studies of Rythmol.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.



On Jul, 15, 2026

59 people who take Rythmol and Gabapentin together, and have interactions are studied.

Rythmol and Gabapentin drug interactions.

What are the common drug interactions of Rythmol and Gabapentin, by gender? *:

female:

  1. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  2. Depression
  3. Drug effect decreased
  4. Dry mouth
  5. Eye infection
  6. Eye pain
  7. Fall
  8. Fatigue (feeling of tiredness)
  9. Gait disturbance
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

male:

  1. Chronic kidney disease
  2. Constipation
  3. Hallucination (an experience involving the perception of something not present)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Back pain
  6. Balance disorder
  7. Chest pain
  8. Dizziness
  9. Dysgeusia (disorder of the sense of taste)
  10. Erectile dysfunction

What are the common drug interactions of Rythmol and Gabapentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Constipation
  2. Depression
  3. Dry mouth
  4. Hypertension (high blood pressure)
  5. Insomnia (sleeplessness)
  6. Spinal disorder (disease of spine a back bone)
  7. Vision blurred
  8. Visual impairment
  9. Weight increased

40-49:

n/a

50-59:

  1. Renal failure (kidney dysfunction)
  2. Renal tubular necrosis (death of kidney tubules)
  3. Ascites (accumulation of fluid in the abdominal cavity)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Cardiovascular disorder (heart diseases)
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  8. Depression
  9. Dermatitis allergic (inflammation of the skin due allergic reaction)
  10. Emotional distress

60+:

  1. Chest pain
  2. Drug ineffective
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Pneumonia
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  8. Anaemia (lack of blood)
  9. Back pain
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the existing conditions these people have? *

  1. Pain: 10 people, 16.95%
  2. High Blood Pressure: 9 people, 15.25%
  3. High Blood Cholesterol: 7 people, 11.86%
  4. Multiple Myeloma (cancer of the plasma cells): 7 people, 11.86%
  5. Neuropathy Peripheral (surface nerve damage): 6 people, 10.17%
  6. Sleep Disorder: 4 people, 6.78%
  7. Asthma: 4 people, 6.78%
  8. Stress And Anxiety: 4 people, 6.78%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 6.78%
  10. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 5.08%

* Approximation only. Some reports may have incomplete information.

Do you take Rythmol and Gabapentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rythmol and Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rythmol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rythmol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on propafenone hydrochloride and gabapentin (the active ingredients of Rythmol and Gabapentin, respectively), and Rythmol and Gabapentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: